Prevention of Hepatocellular Carcinoma
- 7 October 2004
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (15) , 1567-1570
- https://doi.org/10.1056/nejme048237
Abstract
Hepatocellular carcinoma is a significant problem worldwide, and the incidence is increasing in the United States.1 Approximately 90 to 95 percent of these tumors result from the biologic consequences of persistent hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. There are about 450 million chronic carriers of HBV and 200 million carriers of HCV. The general clinical sequence of events is exposure to HBV early in life, and then chronic hepatitis, liver injury and regeneration, development of fibrosis, and cirrhosis. The risk of the development of hepatocellular carcinoma is about 25 to 35 times as high among patients . . .Keywords
This publication has 13 references indexed in Scilit:
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infectionGastroenterology, 2004
- The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An UpdateAnnals of Internal Medicine, 2003
- Week 48 Resistance Surveillance in Two Phase 3 Clinical Studies of Adefovir Dipivoxil for Chronic Hepatitis BHepatology, 2003
- Long‐Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis InfectionThe Journal of Infectious Diseases, 2001
- Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionHepatology, 2001
- Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis BHepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcoholInternational Journal of Cancer, 1999